Analyzing process of evolution and adaptation through acquiring new mutations

FHS
July 29, 2023
4:05 am

The influenza (flu) virus is constantly undergoing a process of evolution and adaptation through acquiring new mutations.

Telix’s prostate cancer imaging kit set for FDA review – Pharmaceutical Technology

Telix already has an FDA-approved imaging agent, a gallium-68 gozetotide injection marketed under the brand name Illuccix. Image credit: Shutterstock / Ezume Images. A day

July 24, 2024

Novel Alzheimer’s Trials Evaluate Senolytics, Semaglutide, CRISPR, and More

In July, we reported that lecanemab (Leqembi) won full FDA approval to treat Alzheimer’s disease. In this article, we look beyond anti-amyloid agents like lecanemab

January 3, 2024

8 Ways AI Will Transform The Future of Healthcare

Palak Shah, Co-Founder and Head of Clinical Operations at Luna The accelerating advances in Artificial Intelligence (AI) have ignited a new era of innovation and

October 30, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.